Intra-amniotic injection of pyridine nucleotides or adenosine triphosphate as countertherapy for 6-aminonicotinamide (6-AN) teratogenesis.
D000014:Abnormalities, Drug-Induced / Q000188:drug therapy / Q000517:prevention & control*; D000255:Adenosine Triphosphate / Q000037:antagonists & inhibitors*; D000650:Amnion; D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects*; D007267:Injections; D008297:Male; D009243:NAD / Q000494:pharmacology*; D009249:NADP / Q000494:pharmacology*; D009536:Niacinamide; D010920:Placenta / Q000187:drug effects*; D051381:Rats
D009243:NAD; D009536:Niacinamide; D009249:NADP; D000255:Adenosine Triphosphate